EUCTR2021-001202-30-NL进行中（未招募）1 期
SARS-CoV-2 immune response
Diakonessenhuis0 个研究点目标入组 400 人开始时间: 2021年4月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Before and after COVID-19 vaccination
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •< 18 years old
研究者
相似试验
招募中
不适用
SARS-CoV-2 immune responseCOVID-1910047438NL-OMON55057Diakonessenhuis Utrecht800
已完成
不适用
Immune response against SARS-CoV-2 vaccinatioCOVID-19DRKS00028174DKFZ6
尚未招募
不适用
Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.JPRN-UMIN000043368agasaki University110
已完成
不适用
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
招募中
4 期
Efficacy of vaccine responses against SARS-Cov-2 in patients with giant cell arteritis and polymyalgia rheumatica (GPSVAC)NL-OMON51139niversitair Medisch Centrum Groningen80